Visit Sight Sciences at ASCRS 2024
Visit us at booth 545 during the ASCRS meeting from Friday, April 5th to Monday, April 8th to engage in insightful peer-to-peer educational discussions, experience TearCare expression sessions firsthand, get hands-on demonstrations, and be among the first to witness our new corporate brand! We look forward to seeing you there!
Red Carpet Event
You are cordially invited to an exclusive red carpet event at our booth (#545), where we will celebrate our shared commitment to elevating eyecare for the benefit of patients. Join us on Saturday, April 6, 2024, from 3:45 PM to 4:30 PM for a toast, hors d’oeuvres, and networking with industry leaders. We look forward to celebrating with you!
This event is not affiliated with the official program of ASCRS 2024.
Meet OMNI and SION Experts
Connect with peers to enhance your understanding of OMNI® and SION® technologies. These one-on-one conversations are an excellent opportunity to ask questions and gain valuable insights about best practices, patient selection, and procedural techniques.
See you at booth 545 on Sunday!
Larissa Camejo, MD
Palm Beach Gardens, Florida
Sunday, April 7 @ 10:30 am - 11:30 am
Arkadiy Yadgarov, MD
Atlanta, Georgia
Sunday, April 7 @ 1:00 pm - 2:00 pm
All presenters are paid consultants of Sight Sciences. This event is not affiliated with the official program of ASCRS 2024.
Expression Sessions
Physician experts in TearCare technology will be conducting live demonstrations at our booth. This is an exceptional opportunity to experience the TearCare treatment firsthand and engage in discussions with these experts about how they are helping their dry eye patients with TearCare.
Friday, April 5
Saturday, April 6
Sunday, April 7
Monday, April 8
All presenters are paid consultants of Sight Sciences. This event is not affiliated with the official program of ASCRS 2024.
Contact Us
Whether you have questions or need assistance, we're here to help.
Our Technologies
OMNI® Surgical System
For Standalone MIGS or Combo Cataract
OMNI enables a comprehensive, implant-free glaucoma procedure that targets three areas of resistance: Schlemm’s canal, Collector channels, and the Trabecular meshwork.
SION® Surgical Instrument
Goniotomy Elevated
With a bladeless tip designed to facilitate a smooth, gentle goniotomy.
TearCare® System
A Better Approach for Treating DED
TearCare delivers the longlasting relief you and your patients need.
Oral and Paper Presentations
OMNI Surgical System
36-Month Outcomes for Canaloplasty and Trabeculotomy Combined with Cataract Surgery: Extended Follow-up from the Gemini Study – oral presentation on Sunday, April 7th at 3:50 PM at the BCEC Meeting level 2 room 259A. Lead author: Arkadiy Yadgarov, MD
TearCare System
Tear Break-up, Meibomian Gland, and Dry Eye Symptom Improvement for Cyclosporine-Treated Patients after Localized Heat Therapy Treatment (SAHARA Cross-Over/phase 2) – oral presentation on Sunday, April 7 at 3:30 PM at the BCEC Meeting level 2, room 259B. Lead author: Brandon Ayres, MD
Rapid Improvement in the Signs and Symptoms of Dry Eye Disease with Localized Heat Therapy (LHT) or Cyclosporine Ophthalmic Emulsion (CsA) (SAHARA subanalysis) – poster presentation. Lead author: Julio Echegoyen, MD
Localized Heat Therapy (LHT) Compared to Cyclosporine Ophthalmic Emulsion (CsA): A Subanalysis on Age, Gender, and Disease Burden – poster presentation. Lead author: Jennifer Loh, MD
Important Product Information
The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. The SION® Surgical Instrument is a sterile, single use, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. Visit SIONsurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.
03/2024 SS-3149-US.v1
In-Booth Presentation
Saturday, April 6th @ 3:15 PM to 3:45 PM
EyeProGPO Booth (#1775)
Discover OMNI and SION: Implant-free technologies by Sight Sciences
Dr. Nathan Radcliffe will share insights about the benefits of performing implant-free, minimally invasive procedures with Sight Sciences' OMNI and SION technologies, now available to all EyeProGPO members.